Sites today have to be agile in order to deliver on unexpected targets and respond rapidly to changes.
UCB’s new antibody facility will be the group’s first large-scale biotechnology production centre. NNE Pharmaplan was in charge of managing the EUR 172 million project.
The annual reports summarise our performance for the year - providing financial and non-financial information.
Engineer with life science experience? Help us develop and deliver complex solutions to demanding customers. And go home smarter every day.
Frank Nygaard, Senior Technology Partner, lets you in on the secrets on how to succesfully create a truly flexible facility for pharmaceutical production.
The pharmaceutical industry is under growing pressure and faces changes, also in manufacturing. What constitutes a successful manufacturing site in the new pharma reality?
© 2013 NNE Pharmaplan